Pamela R. Matias-Garcia,Cavin K. Ward-Caviness,Laura M. Raffield,Xu Gao,Yan Zhang,Rory Wilson,Xin Gao,Jana Nano,Andrew Bostom,Elena Colicino,Adolfo Correa,Brent Coull,Charles Eaton,Lifang Hou,Allan C. Just,Sonja Kunze,Leslie Lange,Ethan Lange,Xihong Lin,Simin Liu,Jamaji C. Nwanaji-Enwerem,Alex Reiner,Jincheng Shen,Ben Schottker,Pantel Vokonas,Yinan Zheng,Bessie Young,Joel Schwartz,Steve Horvath,Ake Lu,Eric A. Whitsel,Wolfgang Koenig,Jerzy Adamski,Juliane Winkelmann,Hermann Brenner,Andrea A. Baccarelli,Christian Gieger,Annette Peters,Nora Franceschini,Melanie Waldenberger

Abstract:Background The difference between an individual's chronological and DNA methylation predicted age (DNAmAge), termed DNAmAge acceleration (DNAmAA), can capture life-long environmental exposures and age-related physiological changes reflected in methylation status. Several studies have linked DNAmAA to morbidity and mortality, yet its relationship with kidney function has not been assessed. We evaluated the associations between seven DNAm aging and lifespan predictors (as well as GrimAge components) and five kidney traits (estimated glomerular filtration rate [eGFR], urine albumin-to-creatinine ratio [uACR], serum urate, microalbuminuria and chronic kidney disease [CKD]) in up to 9688 European, African American and Hispanic/Latino individuals from seven population-based studies. Results We identified 23 significant associations in our large trans-ethnic meta-analysis (p < 1.43E-03 and consistent direction of effect across studies). Age acceleration measured by the Extrinsic and PhenoAge estimators, as well as Zhang's 10-CpG epigenetic mortality risk score (MRS), were associated with all parameters of poor kidney health (lower eGFR, prevalent CKD, higher uACR, microalbuminuria and higher serum urate). Six of these associations were independently observed in European and African American populations. MRS in particular was consistently associated with eGFR (beta = - 0.12, 95% CI = [- 0.16, - 0.08] change in log-transformed eGFR per unit increase in MRS, p = 4.39E-08), prevalent CKD (odds ratio (OR) = 1.78 [1.47, 2.16], p = 2.71E-09) and higher serum urate levels (beta = 0.12 [0.07, 0.16], p = 2.08E-06). The "first-generation" clocks (Hannum, Horvath) and GrimAge showed different patterns of association with the kidney traits. Three of the DNAm-estimated components of GrimAge, namely adrenomedullin, plasminogen-activation inhibition 1 and pack years, were positively associated with higher uACR, serum urate and microalbuminuria. Conclusion DNAmAge acceleration and DNAm mortality predictors estimated in whole blood were associated with multiple kidney traits, including eGFR and CKD, in this multi-ethnic study. Epigenetic biomarkers which reflect the systemic effects of age-related mechanisms such as immunosenescence, inflammaging and oxidative stress may have important mechanistic or prognostic roles in kidney disease. Our study highlights new findings linking kidney disease to biological aging, and opportunities warranting future investigation into DNA methylation biomarkers for prognostic or risk stratification in kidney disease.

Kidney-specific methylation patterns correlate with kidney function and are lost upon kidney disease progression

Meta-analyses identify DNA methylation associated with kidney function and damage

Comparative analysis of epigenetic aging clocks from CpG characteristics to functional associations

DNAm-based Signatures of Accelerated Aging and Mortality in Blood Are Associated with Low Renal Function.

Unraveling the epigenetic code: human kidney DNA methylation and chromatin dynamics in renal disease development

DNA methylation in peripheral blood is associated with renal aging and renal function decline: a national community study

DNA Methylation - and Telomere - Based Biological Age Estimation as Markers of Biological Aging in Donors Kidneys

Epigenetic Clocks: In Aging-Related and Complex Diseases

Age-Related Patterns of DNA Methylation Changes

Time is encoded by methylation changes at clustered CpG sites

Many chronological aging clocks can be found throughout the epigenome: Implications for quantifying biological aging

Predicting exacerbation of renal function by DNA methylation clock and DNA damage of urinary shedding cells: a pilot study

DNA Methylation Clocks in Aging: Categories, Causes, and Consequences

Epigenetic Predictor of Age

DNA methylation correlates of chronological age in diverse human tissue types

DNA methylation aging clocks: challenges and recommendations

DNA methylation-based biomarkers and the epigenetic clock theory of ageing

Altered DNA methylation in kidney disease: useful markers and therapeutic targets

DNA methylation age of blood predicts all-cause mortality in later life

Blood methylation biomarkers are associated with diabetic kidney disease progression in type 1 diabetes

EPIGENETIC PREDICTORS OF LIFESPAN AND HEALTHSPAN